Skip to main content
. 2015 Nov 26;7(1):656–670. doi: 10.18632/oncotarget.6394

Table 4. Top metabolic pathways implicated in progression of melanoma.

Pathway Nevus vs Skin Pr. Mel vs Skin Met. Mel vs Skin Met. Mel vs Pr. Mel Primary vs Nevus
allopregnanolone biosynthesis UP DOWN DOWN DOWN DOWN
citrulline-nitric oxide cycle UP DOWN DOWN DOWN DOWN
dTMP ide novoi biosynthesis mitochondrial DOWN UP UP UP UP
L-carnitine biosynthesis UP DOWN DOWN DOWN DOWN
5-aminoimidazole ribonucleotide biosynthesis DOWN UP UP UP UP
eumelanin biosynthesis UP UP UP DOWN DOWN
putrescine biosynthesis II DOWN DOWN UP UP UP
pyrimidine deoxyribonucleosides salvage DOWN UP UP UP UP
spermine and spermidine degradation I UP DOWN DOWN DOWN DOWN
superpathway of tryptophan utilization UP DOWN DOWN UP DOWN
tryptophan degradation X mammalian via tryptamine UP DOWN DOWN DOWN DOWN
1D-imyoi-inositol hexakisphosphate biosynthesis V from Ins134P3 UP UP DOWN DOWN UP
D-mannose degradation UP UP UP UP DOWN
fructose 26-bisphosphate synthesis, dephosphorylation UP UP UP DOWN DOWN
histamine biosynthesis UP DOWN DOWN DOWN DOWN
inosine-5-phosphate biosynthesis UP UP UP UP DOWN
melatonin degradation II UP DOWN DOWN DOWN DOWN
pyrimidine deoxyribonucleosides degradation UP UP UP DOWN UP
resolvin D biosynthesis UP UP UP DOWN UP
retinoate biosynthesis I DOWN DOWN DOWN UP UP
superpathway of steroid hormone biosynthesis UP DOWN DOWN DOWN DOWN
tRNA charging UP UP UP UP UP
UDP-N-acetyl-D-galactosamine biosynthesis II UP UP UP UP DOWN
valine degradation DOWN DOWN DOWN UP DOWN
zymosterol biosynthesis UP DOWN DOWN DOWN DOWN

UP or DOWN indicates positive and negative difference between the state of interest (nevus, primary and metastatic melanoma) and skin in median PAS value, respectively.